Novartis Wins FDA Approval For Its First Meningitis Vaccine As ACIP Is Set To Meet
The vaccine targets four serotypes, but not the strain that causes the most cases among infants and toddlers, which is the most lucrative market.
The vaccine targets four serotypes, but not the strain that causes the most cases among infants and toddlers, which is the most lucrative market.